Goldman Sachs is a publicly traded company in the Finance sector. As a financial institution, this company is subject to Congressional banking regulation, capital requirement changes, and consumer protection legislation that directly impact operating margins. HillSignal is tracking 8 active Congressional signals mentioning Goldman Sachs, including 8 bills. The current legislative sentiment is predominantly bullish, suggesting potential tailwinds from government policy.
Goldman Sachs ($GS) is currently facing 8 active congressional signals tracked by HillSignal. With 4 bullish, 1 neutral, and 3 bearish signals, the average legislative impact score is 4.9/10. Key sectors affected include Finance and Technology. Recent major catalysts include Main Street Capital Access Act and Climate Change Financial Risk Act of 2025. Below is the complete tracker of government activity affecting Goldman Sachs’s market performance.
AI-detected clusters of bills sharing policy language across their analyses. Concepts are literal phrases present in every member's AI text — not generated narratives.
Thread · 5 bills
Union Calendar · Executive Officers · Bank Holding
The Regulation A+ Improvement Act of 2026 (S.4170) triples SME capital raising limits to $150M, directly expanding fee pools for bulge-bracket investment banks ($GS, $MS, $JPM) and increasing investable product supply on retail fintech platforms ($HOOD, $SOFI, $COIN). The bill is early-stage (referred to Senate Banking Committee, no hearing yet), but related companion bill HR6541 adds cross-chamber momentum. Real market data shows GS (+8.84%), MS (+14.83%), and JPM (+6.29%) over 30 days have partially priced this expansion, while fintechs HOOD (+6.39%), SOFI (+2.71%), and COIN (+7.66%) have lagged the banks.
The ROBINHOOD Act (HR6438) in early-stage committee referral imposes a 20% excise tax on securities-based lending for high-income borrowers, directly threatening a key wealth management revenue stream at Goldman Sachs, Morgan Stanley, and JPMorgan. Current market data shows no price impact from this bill yet — GS at $920.37 (-0.71% 7-day), MS at $188.86 (+0.42% 7-day), JPM at $312.85 (+1.48% 7-day) — as the legislative path is long. But structural risk is real: this product is a sticky, high-margin relationship anchor for wealth management franchises.
HR6955 (Main Street Capital Access Act) passed out of the House Financial Services Committee on 2026-04-20 and is now on the Union Calendar. This is the most significant banking deregulation bill of the 119th Congress. It reduces capital requirements, streamlines merger reviews, modernizes the discount window, and promotes de novo bank formation. Large banks, community banks, and fintech lenders all benefit structurally. Market has already priced in initial momentum with broad banking gains over the last 30 days.
HR7887 is a single-sponsor early-stage bill referred to committee with no legislative momentum. It would prohibit stock sales by senior executives at large banks only if the bank receives a poor regulatory rating. The bill has zero market impact today. All six major bank stocks traded within normal ranges in April 2026 with no event-driven volatility tied to this legislation.
HR7886 (Failed Bank Executives Accountability and Consequences Act) is an early-stage bill expanding FDIC clawback authority over executive compensation for negligence causing bank losses. It increases long-term regulatory risk for all large bank holding companies but has zero near-term revenue impact. Major bank stocks showed mixed 7-day performance as of April 30, 2026, ranging from WFC +2.63% to GS -1.29%, reflecting broader market forces rather than this bill's legislative progress.
The Merchant Banking Modernization Act (HR5291) extends the holding period for merchant banking investments from 10 to 15 years for financial holding companies. The bill is active and on the Union Calendar after passing committee with a 35-17 vote. This is a direct regulatory benefit for large banks engaged in private equity and merchant banking, particularly Goldman Sachs and Morgan Stanley, whose merchant banking divisions are core profit centers. The bill carries no direct federal spending — it is a regulatory change, not an appropriation.
The Climate Change Financial Risk Act of 2025 (HR2823) would impose mandatory biennial climate risk capital evaluations and resolution plans on large U.S. banks. This creates direct compliance costs for JPMorgan, Bank of America, Citigroup, Goldman Sachs, and Morgan Stanley, while generating demand for consulting and IT services from Accenture and IBM. The bill is in early legislative stages with a companion bill in the Senate, but has low near-term passage probability given partisan dynamics and its early committee referral status.
The Regulation A+ Improvement Act of 2025 (HR6541) has been placed on the Union Calendar, tripling the maximum offering amount to $150 million. This expands the capital-raising capacity for small and medium enterprises, directly benefiting investment banks' equity underwriting pipelines. The bill authorizes a regulatory limit increase, not direct government spending, so market impact is structural rather than immediate budget-driven.